Cardiac contractility modulation in patients with heart failure with reduced ejection fraction. IMPULSE-HF a randomized controlled trial

26 May 2019 (09:09 - 09:19)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Doctor Dariusz Jagielski

Centre for Heart Diseases, 4th Military Hospital, Wroclaw (Poland)

12 More presentations in this session

Presentation thumbnail

Pharmacy-based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM-CHF randomized controlled trial

Professor M. Schulz (Leipzig, DE)

Presentation thumbnail

Discussion - PHARM-CHF

Presentation thumbnail

Patiromer to Enable Spironolactone in Patients with Resistant Hypertension and Chronic Kidney Disease (AMBER): Results in the Prespecified Subgroup with Heart Failure

Professor P. Rossignol (Monaco, MC)

Presentation thumbnail

Discussion - AMBER.

Presentation thumbnail

Furosemide Withdrawal in Stable Chronic Outpatients with Heart Failure: a Double-blind, Multicenter, Randomized Trial

Doctor A. Biolo (Porto Alegre, BR)

Access the full session

Session thumbnail

Late breaking trial II - Chronic heart failure

The Event

Heart Failure 2019

26 May 2019 09:09 CET

You may be interested in

Congress Session

Latest advances in cardiac contractility modulation therapy: a new paradigm in heart failure management

30 March 2025

Congress Presentation

The effect of sacubitril/valsartan on device detected arrhythmias and electrical parameters among cardiac resynchronization therapy implanted patients with moderately reduced ejection fraction

29 June 2021

Congress Session

Evolution in pacing and risk management strategies in sudden cardiac death

31 March 2025

Congress Session

Debates in cardiac resynchronisation therapy

30 March 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources